Milestone
Jul 2024
In-Licensed Rosiphersen
CM
Jul 1, 2024
We succesfuly in licensed our lead product, ”Rosiphersen” into AlphaRose Therpauetics from our partner ”The To Cure A Rose Foundation.”
We succesfuly in licensed our lead product, ”Rosiphersen” into AlphaRose Therpauetics from our partner ”The To Cure A Rose Foundation.”